Terms: = Colorectal cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1 AND Treatment
4 results:
1. Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer.
Markt SC; Booker BD; Bensken W; Schiltz NK; Schumacher FR; Rose J; Cooper G; Selfridge JE; Koroukian SM
Cancer Med; 2023 Jan; 12(2):1850-1859. PubMed ID: 35837788
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear receptor coactivator SRC-1 promotes colorectal cancer progression through enhancing GLI2-mediated Hedgehog signaling.
Guo P; Chen Q; Peng K; Xie J; Liu J; Ren W; Tong Z; Li M; Xu J; Zhang Y; Yu C; Mo P
Oncogene; 2022 May; 41(20):2846-2859. PubMed ID: 35418691
[TBL] [Abstract] [Full Text] [Related]
3. Leptin and insulin up-regulate miR-4443 to suppress ncoa1 and TRAF4, and decrease the invasiveness of human colon cancer cells.
Meerson A; Yehuda H
BMC Cancer; 2016 Nov; 16(1):882. PubMed ID: 27842582
[TBL] [Abstract] [Full Text] [Related]
4. cancer in Kashmir, India: burden and pattern of disease.
Rasool MT; Lone MM; Wani ML; Afroz F; Zaffar S; Mohib-ul Haq M
J Cancer Res Ther; 2012; 8(2):243-6. PubMed ID: 22842369
[TBL] [Abstract] [Full Text] [Related]
